FDA Adverse Event Injury Summary report: N

TPRLC 133 MP TYPE1 PPS SO 11.0 T1

MDR report key: 14734021 · Received June 17, 2022

Report

Report Number
0001825034-2022-01431
Event Type
Injury
Date Received
June 17, 2022
Date of Event
February 1, 2022
Report Date
June 17, 2022
Manufacturer
ZIMMER BIOMET, INC.
Product Code
KWA
UDI-DI
00880304514294
PMA / PMN Number
K110400
Removal / Correction Number
N/A
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
FL, US
Reporter Occupation
PHYSICIAN
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

(B)(4). CONCOMITANT MEDICAL PRODUCTS: 110010246 ¿ G7 SHELL ¿ 64809428; 30103606 ¿ G7 LINER ¿ 65051580; 650-0662 ¿ BIOLOX HEAD ¿ 3033498. (B)(4). MEDICAL RECORDS WERE PROVIDED AND REVIEWED BY A HEALTH CARE PROFESSIONAL. REVIEW OF THE AVAILABLE RECORDS IDENTIFIED THE FOLLOWING. FWB WITH ANTALGIC GAIT, ROM: 0-90 DEGREES. HAVING SEVERE PAIN AND PROBLEMS WALKING. REVISION OF FEMORAL COMPONENT ONLY DUE TO STEM SUBSIDENCE. REVIEW OF THE DEVICE HISTORY RECORD(S) IDENTIFIED NO DEVIATIONS OR ANOMALIES DURING MANUFACTURING RELATED TO THE REPORTED EVENT. A DEFINITIVE ROOT CAUSE CANNOT BE DETERMINED. IF ANY FURTHER INFORMATION IS FOUND WHICH WOULD CHANGE OR ALTER ANY CONCLUSIONS OR INFORMATION, A SUPPLEMENTAL WILL BE FILED ACCORDINGLY. ZIMMER BIOMET WILL CONTINUE TO MONITOR FOR TRENDS.

Description of Event or Problem · 0

IT WAS REPORTED THAT PATIENT UNDERWENT A LEFT HIP REVISION APPROXIMATELY 3 MONTHS POST IMPLANTATION DUE TO PAIN AND DIFFICULTY WALKING. DURING THE PROCEDURE, THE FEMORAL COMPONENT WAS NOTED TO HAVE SUBSIDED. THE CUP AND LINER REMAINED IMPLANTED WHILE THE FEMORAL COMPONENTS WERE REMOVED AND REPLACED. ATTEMPTS HAVE BEEN MADE AND ADDITIONAL INFORMATION ON THE REPORTED EVENT IS UNAVAILABLE AT THIS TIME.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
203284 TPRLC 133 MP TYPE1 PPS SO 11.0 T1 PROSTHESIS, HIP KWA ZIMMER BIOMET, INC. N/A 6992251 00880304514294

Patients

Seq Age Sex Outcome Treatment
1 Male Hospitalization| R